Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma.
- Resource Type
- Article
- Source
- Cancer (0008543X); Aug2005, Vol. 104 Issue 3, p561-569, 9p
- Subject
- Language
- ISSN
- 0008543X